New hope to shield kidneys in High-Risk liver transplants
NCT ID NCT04592744
Summary
This study is testing if a drug called angiotensin 2, given during liver transplant surgery, can prevent kidney injury afterward. It will involve about 30 adults with severe liver disease who are receiving a transplant. Half will get the study drug along with standard medications during surgery, and half will get standard care alone, to see if it makes a difference in kidney health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.